Maravai LifeSciences Holdings Inc (MRVI)
7.305
-0.30
(-3.88%)
USD |
NASDAQ |
Apr 19, 16:00
7.30
0.00 (0.00%)
After-Hours: 20:00
Maravai LifeSciences Holdings Cash from Investing (Quarterly): -12.90M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -12.90M |
| September 30, 2023 | -15.52M |
| June 30, 2023 | -24.16M |
| March 31, 2023 | -69.73M |
| December 31, 2022 | -18.52M |
| September 30, 2022 | -5.847M |
| June 30, 2022 | -1.661M |
| March 31, 2022 | -241.58M |
| Date | Value |
|---|---|
| December 31, 2021 | -5.656M |
| September 30, 2021 | 118.63M |
| June 30, 2021 | -4.533M |
| March 31, 2021 | -2.784M |
| December 31, 2020 | -8.849M |
| September 30, 2020 | -10.09M |
| June 30, 2020 | -3.059M |
| March 31, 2020 | 28.07M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-241.58M
Minimum
Mar 2022
118.63M
Maximum
Sep 2021
-17.39M
Average
-7.348M
Median
Cash from Investing (Quarterly) Benchmarks
| ModivCare Inc | -11.14M |
| Dyadic International Inc | 0.0342M |
| Enveric Biosciences Inc | 0.00 |
| Monopar Therapeutics Inc | 2.970M |
| SeaStar Medical Holding Corp | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 7.79M |
| Cash from Financing (Quarterly) | 0.47M |
| Free Cash Flow | 60.67M |
| Free Cash Flow Per Share (Quarterly) | -0.0682 |
| Free Cash Flow to Equity (Quarterly) | -8.196M |
| Free Cash Flow to Firm (Quarterly) | -10.34M |
| Free Cash Flow Yield | 6.30% |